Wei Zhang
Director of Finance/CFO chez CASI PHARMACEUTICALS, INC.
Fortune : 7 274 $ au 31/03/2024
Profil
Wei Zhang is currently the Global President & Chief Financial Officer at CASI Pharmaceuticals, Inc. He previously served as the Chief Executive Officer at Sandoz (China) Pharmaceutical Co., Ltd.
from 2011 to 2016.
He also held the position of President & Chief Financial Officer at CASI Pharmaceuticals, Inc. from 2019 to 2020.
Prior to that, he was the President at Casi Beijing Pharmaceuticals Co. Ltd.
from 2018 to 2019.
Additionally, he worked as the VP, Head-Public Affairs & Corporate Responsibility at Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Dr. Zhang holds an MBA from the University of California, Los Angeles and has completed undergraduate and graduate degrees from the University of Science & Technology of China.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/03/2024 | 2 015 ( 0,02% ) | 7 274 $ | 31/03/2024 |
Postes actifs de Wei Zhang
| Sociétés | Poste | Début |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/09/2019 |
Anciens postes connus de Wei Zhang
| Sociétés | Poste | Fin |
|---|---|---|
Casi Beijing Pharmaceuticals Co. Ltd.
 Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Casi Beijing Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Beijing, China. | President | 01/09/2019 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Chief Executive Officer | 01/01/2016 |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
 Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Corporate Officer/Principal | - |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Director of Finance/CFO | 16/12/2020 |
Formation de Wei Zhang
| University of California, Los Angeles | Masters Business Admin |
| University of Science & Technology of China | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Health Technology |
Casi Beijing Pharmaceuticals Co. Ltd.
Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Casi Beijing Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Beijing, China. | Health Technology |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Health Technology |
